España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Comments
Close menu
Loading...
I-MAB
IMAB
NASDAQ
Watchlist
Leave a Comment
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$1.63
0
0.00%
At Close: -
$1.68
0.05
3.07%
After Hours: Jul 15, 9:03 AM EDT
15 minutes delayed
Get Report
Comment
I-MAB (IMAB) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for I-MAB (NASDAQ:IMAB) Stock
I-MAB Stock (NASDAQ: IMAB)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, July 15, 2024
I-Mab Appointed Wei Fu As New Chair As Dr. Pa...
Benzinga Newsdesk
Wednesday, June 05, 2024
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
I-Mab Enters Clinical Collaboration With Bris...
Benzinga Newsdesk
Tuesday, June 04, 2024
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Tuesday, May 07, 2024
(IMAB) - Analyzing I-MAB's Short Interest
Benzinga Insights
Friday, April 12, 2024
Needham Reiterates Buy on I-MAB, Maintains $6...
Benzinga Newsdesk
Monday, March 18, 2024
NVIDIA To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Monday
Avi Kapoor
Piper Sandler Maintains Overweight on I-MAB, ...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on I-MAB, ...
Benzinga Newsdesk
Friday, March 15, 2024
Needham Maintains Buy on I-MAB, Lowers Price ...
Benzinga Newsdesk
Thursday, March 14, 2024
I-Mab FY23 EPS $(0.76) Vs $(1.63) YoY; Revenu...
Benzinga Newsdesk
Thursday, February 08, 2024
Needham Maintains Buy on I-MAB, Lowers Price ...
Benzinga Newsdesk
Wednesday, February 07, 2024
Looking Into I-MAB's Recent Short Interest
Benzinga Insights
I-Mab Inks Deal To Divest Its Assets And Busi...
Benzinga Newsdesk
Friday, December 15, 2023
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Friday, December 01, 2023
T Investment Reports 9.89% Stake In I-MAB
Benzinga Newsdesk
Thursday, November 02, 2023
I-Mab And HI-Bio Announced An FDA Breakthroug...
Benzinga Newsdesk
Tuesday, October 10, 2023
I-Mab, ABL Bio Announce Latest Updates of PD-...
Benzinga Newsdesk
Thursday, September 28, 2023
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Monday, September 25, 2023
Expert Ratings for I-MAB
Benzinga Insights
Needham Maintains Buy on I-MAB, Lowers Price ...
Benzinga Newsdesk
Friday, September 22, 2023
I-MAB Says Will Continue To Review Follow-Up ...
Benzinga Newsdesk
I-MAB Says Termination Of Agreement Will Take...
Benzinga Newsdesk
I-MAB Says Termination Of Collaboration Agree...
Benzinga Newsdesk
I-MAB Regains Global Rights To Lemzoparlimab;...
Benzinga Newsdesk
Monday, September 11, 2023
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Friday, September 08, 2023
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
Thursday, September 07, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Wednesday, September 06, 2023
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
Tuesday, September 05, 2023
Where I-MAB Stands With Analysts
Benzinga Insights
Cantor Fitzgerald Reiterates Overweight on I-...
Benzinga Newsdesk
Tuesday, August 22, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Friday, August 18, 2023
Analyst Ratings for I-MAB
Benzinga Insights
Cantor Fitzgerald Reiterates Overweight on I-...
Benzinga Newsdesk
HC Wainwright & Co. Maintains Buy on I-MAB, L...
Benzinga Newsdesk
Needham Reiterates Buy on I-MAB, Maintains $2...
Benzinga Newsdesk
Thursday, August 17, 2023
I-MAB H1 EPS $(0.46) Up From $(0.62) YoY, Sal...
Benzinga Newsdesk
Monday, August 14, 2023
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Wednesday, August 09, 2023
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
Tuesday, August 08, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Thursday, July 06, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Wednesday, July 05, 2023
I-Mab Announces Publication Of Claudin18.2 x 4-1BB Bispecific Antibody Givastomig In JITC
Happy Mohamed
Wednesday, June 28, 2023
I-Mab Gets New CEO After Long Search. Sale Of The Company Coming Next?
The Bamboo Works
Thursday, June 22, 2023
Short Volatility Alert: I Mab
Christopher Sappo
I-Mab Announces Appointment Of Raj Kannan As ...
Bill Haddad
Thursday, June 15, 2023
TRACON Commences Court Proceedings In Hong Ko...
Benzinga Newsdesk
Monday, June 05, 2023
5 Analysts Have This to Say About I-MAB
Benzinga Insights
Needham Reiterates Buy on I-MAB, Maintains $2...
Benzinga Newsdesk
Friday, May 26, 2023
I-Mab Reveals Promising Results in Phase 1b/2 Study for Advanced Non-Small Cell Lung Cancer Treatment
Vandana Singh
Thursday, May 25, 2023
I-Mab Reports Phase 1b/2 Study Results Of Pat...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
